REQUEST A DEMO
Total
USD $0.00
Search more companies

MP Apteka N 188 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MP Apteka N 188 Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

MP Apteka N 188 is based in Russia, with the head office in Kirovgrad. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on December 24, 1992. The latest financial highlights indicate a net sales revenue drop of 11.11% in 2022. Its total assets decreased by 22.13% over the same period. The net profit margin of MP Apteka N 188 decreased by 0.01% in 2022.

Headquarters
Zhukovskogo, 10, A, -
Kirovgrad; Sverdlovsk Oblast; Postal Code: 624162

Contact Details: Purchase the MP Apteka N 188 report to view the information.

Basic Information
Outstanding Shares:
Purchase the MP Apteka N 188 report to view the information.
Registered Capital:
Purchase the MP Apteka N 188 report to view the information.
Incorporation Date:
December 24, 1992
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MP Apteka N 188 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-11.11%
Total operating revenue
-11.11%
Operating profit (EBIT)
-21.43%
Net Profit (Loss) for the Period
-33.33%
Total assets
-22.13%
Total equity
-23.28%
Operating Profit Margin (ROS)
-0.3%
Net Profit Margin
-0.01%
Return on Equity (ROE)
-0.01%
Debt to Equity Ratio
-6%
Quick Ratio
0.17%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?